SPC164
Ixekizúmab
Status:
VeittApplication date:
24.8.2016Application published:
15.9.2016Grant published:
15.12.2017
Max expiry date:
27.4.2031Next due date:
31.12.2026Medicine name:
TaltzMedicine for children:
Yes
Timeline
Today
24.8.2016Application
15.9.2016Publication
15.12.2017Registration
27.4.2031Expires
Marketing license
IS authorization number:
EU/1/15/1085/001-003; EU/1/15/1085/004-006Date:
20.5.2016
Foreign authorization number:
EU/1/15/1085Date:
25.4.2016
Owner
Name:
ELI LILLY AND COMPANYAddress:
Lilly Corporate Center, Indianapolis US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1963368